Collectively, our results demonstrated that kaempferol induces apoptosis in pancreatic cancer cells via ROS-mediated Akt/mTOR pathway inactivation, and that pharmacological inhibition of TGM2 by kaempferol in vitro and in vivo may provide a novel treatment option for the treatment of pancreatic cancer. This evidence concerns the gene AKT1 and pancreatic neoplasm.